Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers

Song W, etc||Vanderbilt University School of Medicine
Song W & etc. (). Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers. , doi: 10.1038/onc.2017.170

Referred Product